BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 4.72

Change

-0.38 (-7.45)%

Market Cap

USD 1.60B

Volume

3.08M

Analyst Target

USD 26.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-1.82 (-1.22%)

USD 66.32B
HLN Haleon plc

-0.03 (-0.29%)

USD 45.41B
TAK Takeda Pharmaceutical Co Ltd A..

+0.22 (+1.50%)

USD 43.84B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 11.39B
ELAN Elanco Animal Health

+0.04 (+0.47%)

USD 4.28B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.23 (-3.13%)

USD 3.25B
CPHI China Pharma Holdings Inc

N/A

USD 4.61M
YCBD cbdMD Inc

N/A

USD 1.44M
EVT Eaton Vance Tax Advantaged Div..

-0.58 (-2.72%)

N/A
TEVA Teva Pharma Industries Ltd ADR

-0.34 (-2.49%)

N/A

ETFs Containing BHC

MJJ 9.90 % 0.00 %

N/A

N/A
MJO 9.90 % 0.00 %

N/A

N/A
ITA iShares U.S. Aerospace & .. 8.76 % 0.42 %

-3.09 (0.00%)

USD 3.70B
XSD2:LSE db x-trackers ShortDAX x2.. 5.61 % 0.00 %

N/A

USD 0.11B
DBPD:F Xtrackers - ShortDAX x2 D.. 5.61 % 0.00 %

N/A

N/A
GNOM Global X Genomics & Biote.. 4.40 % 0.00 %

+0.06 (+0.00%)

USD 0.05B
FMK 4.35 % 0.70 %

N/A

N/A
ROKT SPDR S&P Kensho Final Fro.. 4.15 % 0.00 %

-1.32 (0.00%)

USD 0.02B
PFF iShares Preferred and Inc.. 3.58 % 0.46 %

-0.24 (0.00%)

N/A
BUZ 3.50 % 0.75 %

N/A

N/A
SXLI:LSE SPDR S&P U.S. Industrials.. 3.17 % 0.00 %

N/A

N/A
ZPDI:F SPDR S&P U.S. Industrials.. 3.17 % 0.00 %

N/A

USD 0.24B
ZPDI:XETRA SPDR S&P U.S. Industrials.. 3.17 % 0.00 %

N/A

N/A
IISU:LSE iShares S&P 500 Industria.. 3.06 % 0.00 %

N/A

N/A
IUIS:LSE iShares S&P 500 Industria.. 3.06 % 0.00 %

N/A

USD 0.46B
VIS Vanguard Industrials Inde.. 2.40 % 0.10 %

-5.74 (0.00%)

N/A
UXI ProShares Ultra Industria.. 2.35 % 0.95 %

-1.46 (0.00%)

N/A
IYJ iShares U.S. Industrials .. 1.95 % 0.42 %

-2.62 (0.00%)

USD 0.94B
WNDU:LSE SPDR® MSCI World Industr.. 1.69 % 0.00 %

N/A

N/A
XDWI:LSE Xtrackers MSCI World Indu.. 1.69 % 0.00 %

N/A

N/A
XDWI:F Xtrackers MSCI World Indu.. 1.69 % 0.00 %

N/A

USD 0.40B
XDWI:XETRA Xtrackers MSCI World Indu.. 1.69 % 0.00 %

N/A

N/A
EXI iShares Global Industrial.. 1.63 % 0.46 %

-1.95 (0.00%)

N/A
OEW 1.25 % 0.40 %

N/A

N/A
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.86 % 0.00 %

N/A

USD 0.20B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.84 % 0.00 %

N/A

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.84 % 0.00 %

N/A

N/A
SJNK:SW SPDR® Bloomberg SASB U.S.. 0.84 % 0.00 %

N/A

USD 0.20B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.74 % 0.00 %

N/A

N/A
BND Vanguard Total Bond Marke.. 0.01 % 0.04 %

-0.40 (0.00%)

N/A
BSJL 0.00 % 0.41 %

N/A

N/A
CJNK 0.00 % 0.30 %

N/A

N/A
FIW First Trust Water ETF 0.00 % 0.55 %

-1.90 (0.00%)

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

-0.46 (0.00%)

N/A
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
RFUN 0.00 % 0.51 %

N/A

N/A
RGI Invesco S&P 500® Equal W.. 0.00 % 0.40 %

N/A

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

-0.16 (0.00%)

USD 0.15B
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

-0.15 (0.00%)

CAD 0.05B
HYGV FlexShares® High Yield V.. 0.00 % 0.37 %

-0.30 (0.00%)

USD 1.28B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.00 %

-0.11 (0.00%)

USD 0.26B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

+0.09 (+0.00%)

USD 0.15B
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

+0.01 (+0.00%)

USD 2.55B
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

-0.17 (0.00%)

N/A
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

-0.21 (0.00%)

USD 3.37B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

-0.11 (0.00%)

USD 0.96B
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

N/A

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

N/A
XGLF:LSE db x-trackers MSCI GCC Se.. 0.00 % 0.00 %

N/A

N/A
SYBJ:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.55B
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

N/A

N/A
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

-0.13 (0.00%)

USD 0.10B
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -41.44% 14% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.44% 14% F 4% F
Trailing 12 Months  
Capital Gain -44.14% 14% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.14% 14% F 6% D-
Trailing 5 Years  
Capital Gain -71.15% 31% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.15% 31% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain -8.89% 14% F 8% B-
Dividend Return -8.89% 14% F 6% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 47.06% 36% F 18% F
Risk Adjusted Return -18.88% 21% F 12% F
Market Capitalization 1.60B 33% F 66% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector